ABACAVIR AND LAMIVUDINE
Generic: ABACAVIR AND LAMIVUDINE
Laurus Labs LimitedManufacturer
ORALRoute
ABACAVIR SULFATEActive Substance
2022-07-25Original Approval
ABACAVIR AND LAMIVUDINE is FDA application ANDA216332, sponsored by LAURUS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
EXPOSURE DURING PREGNANCY
24 reports
2
OFF LABEL USE
20 reports
3
FOETAL EXPOSURE DURING PREGNANCY
19 reports
4
HEADACHE
18 reports
5
HYPERSENSITIVITY
18 reports
6
HEPATIC ENZYME INCREASED
17 reports
7
HYPERTENSION
17 reports
8
RASH
17 reports
9
PAIN
15 reports
10
PYREXIA
15 reports